Institute of Oncology Ljubljana
🇸🇮Slovenia
Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer
Phase 2
- Conditions
- Rectal Cancer
- First Posted Date
- 2008-06-04
- Last Posted Date
- 2012-03-26
- Lead Sponsor
- Institute of Oncology Ljubljana
- Target Recruit Count
- 43
- Registration Number
- NCT00689702
- Locations
- 🇸🇮
Institute of Oncology, Ljubljana, Slovenia
© Copyright 2025. All Rights Reserved by MedPath